Anshan Hifichem Co Ltd
Anshan Hifichem Co., Ltd. engages in the research, development, manufacture, and sale of high-performance organic pigments, dyestuff, and intermediates in China. It offers lead chrome yellow and molybate orange pigments, solvent dyestuff, and inks for use in various industries, such as Vehicle paint and refinish paint, industrial coating, powder coating, 3c coatings, construction, architecture pa… Read more
Anshan Hifichem Co Ltd (300758) - Total Liabilities
Latest total liabilities as of September 2025: CN¥1.94 Billion CNY
Based on the latest financial reports, Anshan Hifichem Co Ltd (300758) has total liabilities worth CN¥1.94 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Anshan Hifichem Co Ltd - Total Liabilities Trend (2014–2024)
This chart illustrates how Anshan Hifichem Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Anshan Hifichem Co Ltd Competitors by Total Liabilities
The table below lists competitors of Anshan Hifichem Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.
SHE:301096
|
China | CN¥1.29 Billion |
|
Nutex Health Inc
NASDAQ:NUTX
|
USA | $495.09 Million |
|
Lenzing Aktiengesellschaft
PINK:LNZNF
|
USA | $3.39 Billion |
|
Fujian MinDong Electric Power Co Ltd
SHE:000993
|
China | CN¥1.04 Billion |
|
OSAKA Titanium technologies Co.Ltd
F:S5M
|
Germany | €60.69 Billion |
|
Guangzhou Grandbuy Co Ltd
SHE:002187
|
China | CN¥3.06 Billion |
|
AB Ignitis grupe
IL:IGN
|
UK | €3.61 Billion |
Liability Composition Analysis (2014–2024)
This chart breaks down Anshan Hifichem Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.50 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Anshan Hifichem Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Anshan Hifichem Co Ltd (2014–2024)
The table below shows the annual total liabilities of Anshan Hifichem Co Ltd from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.84 Billion | +10.01% |
| 2023-12-31 | CN¥1.67 Billion | +27.59% |
| 2022-12-31 | CN¥1.31 Billion | +60.28% |
| 2021-12-31 | CN¥817.79 Million | +38.43% |
| 2020-12-31 | CN¥590.77 Million | +86.59% |
| 2019-12-31 | CN¥316.62 Million | +40.04% |
| 2018-12-31 | CN¥226.09 Million | +24.70% |
| 2017-12-31 | CN¥181.31 Million | -9.59% |
| 2016-12-31 | CN¥200.53 Million | -3.06% |
| 2015-12-31 | CN¥206.86 Million | -27.78% |
| 2014-12-31 | CN¥286.42 Million | -- |